Codony-Servat el al. showed that in colorectal carcinoma cells treated with IGF-IR-blocking antibodies, nuclear translocation increased, suggesting that nuclear sequestration of the receptor could contribute to therapy resistance [9]. Here, IGF1R is linked to colorectal carcinoma.